Artificial Iris Market Size, Share, Industry, Forecast and outlook (2024-2031)

Artificial Iris Market is segmented By Material (Fiber, Fiber-Free, Silicone, PMMA (Polymethyl Methacrylate), Others), By Color (Blue, Brown, Green, Others), By Age Group (Adult, Pediatric), By Application (Cosmetic, Therapeutic), By End-User (Hospital, Specialty Clinics, Aesthetic Clinics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Artificial Iris Market Size

Global Artificial Iris Market reached US$ YY billion in 2022 and is expected to reach US$ YY billion by 2030, growing with a high CAGR during the forecast period 2023-2030.

The global artificial iris market witnessing significant growth and transformations in recent years, with various factors influencing its dynamics such as increasing adoption in aesthetic clinics, and others. The artificial iris is a surgically implanted device to treat damage or absence of the iris of the eye which is commonly known as aniridia. The artificial iris is fiber and non-fiber material types, they are available for both adult patients and pediatric patients in blue, brown, green, and other colors.

Moreover, they are mostly used for cosmetic and therapeutic applications. The non-fiber segment is expected to hold the largest market share over the forecast period. Similarly, North America dominates the market, capturing the largest market share owing to the increasing adoption of artificial iris in aesthetic procedures and the presence of major players. 

 Owing to the increasing prevalence of aniridia, increasing awareness, increasing adoption of artificial iris, and technological advancements in artificial iris are the major factors expected to drive the global artificial iris market over the forecast period.

Artificial Iris Market Scope

For More Insights Request Free Sample

Artificial Iris Market Dynamics

Increasing Adoption of Artificial Iris is Expected to Drive the Growth of the Market

The increasing adoption of artificial iris is expected to drive the growth of the market over the forecast period. They are mostly considered for their aesthetic appearance, so adoption of the artificial iris is increasing in aesthetic clinics. The increasing awareness about the availability and the benefits of artificial iris devices can increase the adoption of these devices. Patients who previously may not have known about this option may now consider it for both therapeutic and cosmetic options.

Further, advances in surgical techniques, including minimally invasive procedures, have made artificial iris implantation safer and more accessible. Surgeons' ability to successfully perform these surgeries contributes to patient trust and adoption. Many artificial iris implants are now customizable to match the patient's natural eye color and size. This level of personalization appeals to patients seeking a natural appearance. Many advanced technologies like AI also using to improve clinical and aesthetic benefits.

For instance, on May 25, 2023, IRIS The Visual Group, a banner of the New Look Vision Group, launched Artificial IRIS, a breakthrough artificial intelligence technology for the optometry industry in Quebec, in partnership with Montreal-based DIAGNOS. This state-of-the-art tool uses AI to enhance clinical testing and detect early signs of retinal abnormalities, the companies said. For over two years, IRIS and DIAGNOS have joined forces to advance and combine technological innovations and provide front-line clinical experience to improve patient care through early detection and follow-up of various ocular diseases, with the training of DIAGNOS algorithms and with the help of annotations from 30 IRIS optometrists.

Increasing Prevalence of Aniridia is Also Expected to Drive the Growth of the Market

The increasing prevalence of aniridia is also expected to drive the growth of the market over the forecast period. Aniridia is characterized by partial or complete absence of the iris. The first line treatment for the aniridia is implantation of the artificial iris. Many individuals with aniridia seek treatment not only for functional improvements but also for aesthetic reasons. Artificial iris implants can provide a more natural appearance to the eye, which can be especially important for patients' self-esteem and quality of life.

For instance, The ARTIFICIALIRIS from HumanOptics is the world’s unique foldable iris prosthesis, for both medical and aesthetic reconstruction of eyes with complete or partial aniridia.

Further, as awareness about eye conditions especially aniridia increases among patients and healthcare professionals, more cases are likely to be diagnosed. This leads to a growing patient pool in need of treatment, including artificial iris implants.  Advances in surgical techniques have made artificial iris implantation safer and more effective. Surgeons are becoming more proficient in performing these procedures, which can boost patient confidence in seeking treatment.

Complications Associated with the Implantation of Artificial Iris is Expected to Hamper the Market's Growth

There are many complications associated with the implantation of artificial iris, which is expected to hamper the market growth over the forecast period. Implantation of artificial irises mainly involves surgery, which inherently carries risks, including infection, bleeding, and anesthesia-related complications. The perception of these risks may deter some patients from opting for the procedure.

Additionally, complications directly related to the artificial iris implant can include malpositioning, dislocation, or extrusion of the iris. These issues may require corrective surgeries and can result in patient dissatisfaction. Post-operative infections can lead to serious complications and vision impairment. Infections can occur at the surgical site or within the eye, and they may require antibiotic treatment or device removal.

Artificial Iris Market Segmentation Analysis

The global artificial iris market is segmented based on material, color, age group, application, end-user, and region.

The Fiber-free Segment Accounted for Approximately 59.2% of the Vitiligo Treatment Market Share

The fiber-free artificial iris segment is expected to hold the largest market share over the forecast period. The materials used in fiber-free artificial irises, such as silicone or PMMA, are well-tolerated by the body by reducing the risk of adverse reactions and further complications. The Fiber-Free model is suitable for sutureless implant techniques or can be sutured.  The Fiber-Free model can be implanted as a full diaphragm either within the ciliary sulcus or within the capsular bag. 

Moreover, fiber-free artificial irises are designed to withstand the rigors of daily eye movement and function without deteriorating over time. Many fiber-free artificial iris implants can be customized to match the patient's natural eye color, size, and appearance, providing a more natural look. Fiber-free artificial iris implants are often more cost-effective than some other advanced technologies, making them accessible to a broader patient population.

Artificial Iris Market Geographical Share

North America Accounted for Approximately 38.2% of the Market Share in 2022, Owing to the Strong Presence of Major Players and the Increasing Adoption of Artificial Iris

North America region is expected to hold the largest market share over the forecast period owing to the strong presence of major players and increasing adoption of artificial iris in aesthetic procedures. North America especially the United States and Canada is home to many pharmaceutical and medical device companies, the strong presence of major players helps to perform research activities and clinical trials to develop artificial iris devices with advanced technologies.

Furthermore, in North America, the prevalence of aniridia is increasing so there is a continuous adoption of the artificial iris in the region. For instance, according to the National Institute of Health (NIH), the prevalence of aniridia is 1 in 40,000 to 1 in 100,000 in the United States.  This increasing prevalence is expected to drive the artificial iris by offering an aesthetic appearance. This leads to market dominance in the region.

Artificial Iris Companies

The major global players in the artificial iris market include HumanOptics Holding AG, REPER-NN LTD, Kestrel Ophthalmics Inc., VEO Ophthalmics, LLC., InsEYEt, LLC, Spectrum Surgical, Vistek Company, MicroSurgical Technology, Iris ID, Inc., and Pixium Vision, among others. 

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for pharmaceutical industries worldwide, including the global artificial iris market. During the pandemic, many research activities, and regulatory approvals have been temporarily postponed due to the redirected focus on the COVID-19 pandemic and its related restrictions.

The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular eye check-ups, appointments, and consultations worldwide. Many hospitals are focused on COVID-19 cases, this reduced eye-related treatments like aniridia, which reduces the demand for artificial iris during the onset of the pandemic.

Moreover, the COVID-19 pandemic severely disrupted global supply chains, impacting the transportation of artificial iris devices. Movement restrictions and border closures delayed shipments and caused transportation delays. Additionally, some countries faced shortages of artificial iris for the treatment of aniridia due to disruptions in their supply chain networks.

Why Purchase the Report?

• To visualize the global artificial iris market segmentation based on material, color, age group, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of artificial iris market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global artificial iris market report would provide approximately 61 tables, 58 figures, and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies